|
Re: A clinical future for RVX-2135 or just a pre-clinical tool
|
5
|
Zenith Epigenetics
|
Aug 12, 2017 05:53PM
|
|
Re: A Cluster muck....
|
5
|
Resverlogix Corp.
|
Jun 06, 2019 05:54PM
|
|
Re: A comment about market penetration
|
2
|
Resverlogix Corp.
|
Mar 20, 2017 06:34PM
|
|
Re: A comment by BDZ on SH...
|
3
|
Resverlogix Corp.
|
Apr 27, 2017 11:43AM
|
|
Re: A couple from the "Cardiology Top 10" this month.
|
1
|
Resverlogix Corp.
|
Feb 02, 2018 03:13AM
|
|
Re: A couple from the "Cardiology Top 10" this month.
|
|
Resverlogix Corp.
|
Feb 02, 2018 12:14PM
|
|
Re: A couple of recent RVX-208 articles related to selective bromodomain inhibition
|
6
|
Resverlogix Corp.
|
Sep 13, 2017 08:29PM
|
|
Re: A couple of recent RVX-208 articles related to selective bromodomain inhibition
|
9
|
Resverlogix Corp.
|
Sep 14, 2017 01:22AM
|
|
Re: A couple Q2 events for Zenith
|
2
|
Zenith Epigenetics
|
May 10, 2017 10:40AM
|
|
Re: A couple Q2 events for Zenith
|
3
|
Zenith Epigenetics
|
May 10, 2017 12:32PM
|
|
Re: A couple Q2 events for Zenith
|
1
|
Zenith Epigenetics
|
May 10, 2017 12:54PM
|
|
Re: A couple that may be of interest while we wait...
|
3
|
Resverlogix Corp.
|
Aug 09, 2018 10:55AM
|
|
Re: A fair and optimistic write up on BETonMACE
|
2
|
Resverlogix Corp.
|
Nov 25, 2019 01:12PM
|
|
Re: A fair and optimistic write up on BETonMACE
|
2
|
Resverlogix Corp.
|
Nov 25, 2019 01:12PM
|
|
Re: A few comments
|
2
|
Resverlogix Corp.
|
Jan 10, 2017 03:51PM
|
|
Re: A few comments
|
4
|
Resverlogix Corp.
|
Jan 12, 2017 02:24PM
|
|
Re: A few comments
|
2
|
Resverlogix Corp.
|
Jan 12, 2017 04:22PM
|
|
Re: A few comments
|
5
|
Resverlogix Corp.
|
Jan 11, 2017 08:09PM
|
|
Re: A few things
|
5
|
Resverlogix Corp.
|
Oct 17, 2017 08:22PM
|
|
Re: A lesson on futility analyses from the CETP inhibitors
|
5
|
Resverlogix Corp.
|
May 11, 2017 11:50PM
|
